Clinical Trial

Tafenoquine and ACTs (TADORE- Plus)

Study acronym: TADORE+
Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
A trial designed to determine whether there is a clinically significant drug-drug interaction of tafenoquine with DHA-piperaquine or artesunate-pyronaridine using a control arm with radical cure given at the end of follow up (delayed radical cure).
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-07-02; most recent amendment 2026-03-16.
Trial Details
NCT Number NCT07060794
Lead Sponsor Menzies School of Health Research
Conditions Vivax Malaria
Enrollment 507 participants
Start Date 2026-06
Primary Completion 2028-06 (estimated)
Study Completion 2028-06 (estimated)
Updated on ClinicalTrials.gov 2026-03-18